The Sriwijaya University Library

  • Home
  • Information
  • News
  • Help
  • Login
  • Librarian
  • Member Area
  • Select Language :
    Arabic Bengali Brazilian Portuguese English Espanol German Indonesian Japanese Malay Persian Russian Thai Turkish Urdu

Search by :

ALL Author Subject ISBN/ISSN Advanced Search

Last search:

{{tmpObj[k].text}}
Image of PERBANDINGAN KADAR INSULIN ANTIBODY (IA) PADA PASIEN DIABETES MELITUS TIPE 2 YANG MENDAPATKAN INSULIN GLARGIN ANALOG ORIGINATOR DENGAN INSULIN GLARGIN BIOSIMILAR DI RUMAH SAKIT MOHAMMAD HOESIN PALEMBANG
Bookmark Share

Skripsi

PERBANDINGAN KADAR INSULIN ANTIBODY (IA) PADA PASIEN DIABETES MELITUS TIPE 2 YANG MENDAPATKAN INSULIN GLARGIN ANALOG ORIGINATOR DENGAN INSULIN GLARGIN BIOSIMILAR DI RUMAH SAKIT MOHAMMAD HOESIN PALEMBANG

Pratiwi, Tria Ayu - Personal Name;

Background: The use of biosimilar insulin glargine offers a more economical therapeutic alternative compared to the originator product in the management of Type 2 Diabetes Mellitus (T2DM). However, differences in manufacturing processes for biological products have the potential to trigger different immune responses, one of which is the formation of Insulin Antibodies (IA). This study aims to compare IA levels between patients using insulin glargine analogue originator and insulin glargine biosimilar to evaluate their immunogenicity safety profile. Methods: This study was an analytic observational study with a cross-sectional design conducted at Dr. Mohammad Hoesin Hospital Palembang from October to December 2025. The study subjects consisted of 72 T2DM patients who met the inclusion criteria, divided into two groups: 36 patients using insulin glargine analogue originator and 36 patients using insulin glargine biosimilar. IA levels were measured using the ELISA (Enzyme-Linked Immunosorbent Assay) method. Statistical analysis was performed using the Mann-Whitney test to compare IA levels between the two groups. Results: Demographic characteristics and laboratory parameters (renal function, liver function, and lipid profile) were relatively equivalent between the two groups, although there was a significant difference in the duration of insulin use, which was longer in the originator group. Measurement results showed a median IA level in the originator group of 0.1667 ng/mL (range 0.0671–0.3945 ng/mL), while in the biosimilar group, it was 0.1670 ng/mL (range 0.0473–0.5214 ng/mL). Statistical tests showed no significant difference in IA levels between the two groups (p=0.710). Conclusion: There was no significant difference in Insulin Antibody (IA) levels between T2DM patients receiving insulin glargine analogue originator therapy and those receiving biosimilar. This indicates that insulin glargine biosimilar has an immunogenicity profile comparable to the originator product, making it safe for use as a therapeutic alternative. Keywords: Type 2 Diabetes Mellitus, Insulin Glargine, Biosimilar, Originator, Insulin Antibody (IA)



Availability
#
Central Library (Reference) T1956842026
T195684
Available but not for loan - Not for Loan
Detail Information
Series Title
-
Call Number
T1956842026
Publisher
Indralaya : Prodi Pendidikan Dokter Spesialis 1 Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Sriwijaya., 2026
Collation
xx, 107 hlm.; ilus.; 29 cm
Language
Indonesia
ISBN/ISSN
-
Classification
616.462 07
Content Type
Text
Media Type
unmediated
Carrier Type
-
Edition
-
Subject(s)
Diabetes Melitus Tipe 2
Specific Detail Info
-
Statement of Responsibility
KA
Other version/related
TitleEditionLanguage
PENGEMBANGAN APLIKASI DIABETES CARE SEBAGAI SELF CARE MANAGEMENT DALAM PENGENDALIAN KADAR GLUKOSA DARAH PADA PENDERITA DIABETES MELITUS TIPE 2 BERBASIS ANDROIDid
RASIONALITAS PENGGUNAAN ANTIDIABETIKA ORAL PADA PASIEN RAWAT INAP DIABETES MELITUS TIPE 2 DI RSUD PALEMBANG BARI PERIODE 1 SEPTEMBER 2010-31 AGUSTUS 2011id
GAMBARAN EKOKARDIOGRAFI DISFUNGSI DIASTOLIK ASIMPTOMATIK PADA PENDERITA DIABETES MELITUS TIPE 2 DI POLIKLINIK ENDOKRIN METABOLIK RSMH PALEMBANGid
File Attachment
  • PERBANDINGAN KADAR INSULIN ANTIBODY (IA) PADA PASIEN DIABETES MELITUS TIPE 2 YANG MENDAPATKAN INSULIN GLARGIN ANALOG ORIGINATOR DENGAN INSULIN GLARGIN BIOSIMILAR DI RUMAH SAKIT MOHAMMAD HOESIN PALEMBANG
Comments

You must be logged in to post a comment

The Sriwijaya University Library
  • Information
  • Services
  • Librarian
  • Member Area

About Us

As a complete Library Management System, SLiMS (Senayan Library Management System) has many features that will help libraries and librarians to do their job easily and quickly. Follow this link to show some features provided by SLiMS.

Search

start it by typing one or more keywords for title, author or subject

Keep SLiMS Alive Want to Contribute?

© 2026 — Senayan Developer Community

Powered by SLiMS
Select the topic you are interested in
  • Computer Science, Information & General Works
  • Philosophy & Psychology
  • Religion
  • Social Sciences
  • Language
  • Pure Science
  • Applied Sciences
  • Art & Recreation
  • Literature
  • History & Geography
Icons made by Freepik from www.flaticon.com
Advanced Search
Where do you want to share?